MIC lipotropic blend

Educational overview

Compounded mixture with no standard formula or FDA-approved general-wellness indication; record the exact ingredients and concentration.

MIC is an abbreviation for methionine, inositol and choline, three nutrients combined in a compounded injectable that weight-loss and wellness clinics market as a lipotropic or fat-burning shot. Methionine is an essential sulphur-containing amino acid, inositol is a sugar alcohol involved in cell signalling, and choline is an essential nutrient required for phospholipid synthesis and fat transport out of the liver. The word lipotropic dates from mid-twentieth-century animal nutrition, where choline and methionine were shown to prevent fatty liver in deficient rats. Many products add vitamin B12, other B vitamins or levocarnitine, and the proportions vary from pharmacy to pharmacy, so MIC names a category rather than a defined drug.

There are no published randomised controlled trials of MIC injections for weight loss, body composition or liver fat in people, and no systematic review has been possible because the primary studies do not exist. The individual nutrients are well characterised in a different context: the Institute of Medicine's 1998 Dietary Reference Intakes report set an adequate intake and an upper limit for choline based on human depletion studies showing liver damage when choline is withheld, and the NIH Office of Dietary Supplements summarises the same evidence. Those findings concern correcting dietary deficiency by mouth; they do not show that injecting the nutrients into well-nourished adults changes fat metabolism, and the leap from one to the other is untested.

No MIC product is approved by the FDA, the EMA or comparable regulators, and none has an authorised indication for weight management. In the United States the blends are prepared by compounding pharmacies from bulk ingredients under section 503A or by outsourcing facilities under 503B, which means they are not reviewed for safety, effectiveness or quality before sale. The FDA has acted against unapproved injectable nutrient products in this category; a 2015 alert told clinicians not to use injectable vitamin products labelled Sunshine Labs, including several MIC and MIC-with-B12 vials, because they were manufactured abroad and sold as prescription nutritional injections without approval. Outside the United States, similar products fall under national rules for unlicensed compounded medicines.

Storage and in-use limits for a compounded MIC vial come only from the dispensing pharmacy's label, which states the beyond-use date, the temperature range and whether the vial is single- or multi-dose. Because formulas differ, two vials described as MIC may contain different ingredients at different concentrations, sometimes with vitamin B12 or carnitine added. An inventory record that transcribes the exact ingredient list, concentration of each component, pharmacy, lot number and beyond-use date is what makes a dose log meaningful; the abbreviation alone identifies nothing. Multi-dose vials of sterile compounded products also carry contamination risk once punctured, so recording first-use dates alongside the pharmacy's stated in-use period preserves the information needed to interpret the record later.

Category

Compounded vitamin / amino-acid blend

Routes represented

Subcutaneous (SubQ)

Storage context

Follow the product or pharmacy label; requirements vary by route and formulation.